Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 4, 2009, Pages

  Sacconi, S ^a   Simkin, D ^b   Arrighi, N ^a   Chapon, F ^c   Larroque, M M ^b   Vicart, S ^d,f,g   Sternberg, D ^e,f   Fontaine, B ^d   Barhanin, J ^b   Desnuelle, C ^a   Bendahhou, S ^b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d Centre de Référence des Canalopathies Musculaires   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g Institut National de la Sante   (France)

Author keywords

Andersen's syndrome; Potassium ion channels; Skeletal muscle

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1;

ADULT; AGED; ARTICLE; CASE REPORT; CELL COUNT; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ELECTRIC POTENTIAL; EX VIVO STUDY; GENE; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 4; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; ION CURRENT; KCNJ2 GENE; MALE; MEMBRANE STEADY POTENTIAL; MUSCLE BIOPSY; MUSCLE TISSUE; MUSCLE WEAKNESS; MYOBLAST; MYOTUBE; PATCH CLAMP; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RARE DISEASE; SKELETAL MUSCLE;

ADULT; AGED; ANDERSEN SYNDROME; CELLS, CULTURED; HUMANS; ION TRANSPORT; MALE; MEMBRANE POTENTIALS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; MYOBLASTS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 70349929474     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00519.2008     Document Type: Article

References (30)

1. Abbott GW, Butler MH, Bendahhou S, Dalakas MC, Ptáček LJ, Goldstein SA. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 104: 217-231, 2001. (Pubitemid 32174838)
2. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL, Benson DW. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 71: 663-668, 2002. (Pubitemid 34970139)
3. Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 60: 559-564, 1971.
4. Ballester LY, Benson DW, Wong B, Law IH, Mathews KD, Vanoye CG, George AL. Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome (Abstract). Hum Mutat 27: 388, 2006.
5. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptáček LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem 278: 51779-51785, 2003. (Pubitemid 38020424)
6. Bendahhou S, Fournier E, Gallet S, Menard D, Larroque MM, Barhanin J. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred. Hum Mol Genet 16: 900-906, 2007. (Pubitemid 47062735)
7. Bendahhou S, Fournier E, Sternberg D, Bassez G, Furby A, Sereni C, Donaldson MR, Larroque MM, Fontaine B, Barhanin J. In vivo and in vitro functional characterization of Andersen's syndrome mutations. J Physiol (Lond) 565: 731-741, 2005. (Pubitemid 40903288)
8. Bryant SH. Cable properties of external intercostal muscle fibres from myotonic and nonmyotonic goats. J Physiol (Lond) 204: 539-550, 1969.
9. Davies NP, Imbrici P, Fialho D, Herd C, Bilsland LG, Weber A, Mueller R, Hilton-Jones D, Ealing J, Boothman BR, Giunti P, Parsons LM, Thomas M, Manzur AY, Jurkat-Rott K, Lehmann-Horn F, Chinnery PF, Rose M, Kullmann DM, Hanna MG. Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology 65: 1083-1089, 2005. (Pubitemid 41429635)
10. Donaldson MR, Jensen JL, Tristani-Firouzi M, Tawil R, Bendahhou S, Suarez WA, Cobo AM, Poza JJ, Behr E, Wagstaff J, Szepetowski P, Pereira S, Mozaffar T, Escolar DM, Fu YH, Ptáček LJ. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology 60: 1811-1816, 2003.
11. Eckhardt LL, Farley AL, Rodriguez E, Ruwaldt K, Hammill D, Tester DJ, Ackerman MJ, Makielski JC. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties. Heart Rhythm 4: 323-329, 2007. (Pubitemid 46323455)
12. Fischer-Lougheed J, Liu JH, Espinos E, Mordasini D, Bader CR, Belin D, Bernheim L. Human myoblast fusion requires expression of functional inward rectifier Kir2.1 channels. J Cell Biol 153: 677-686, 2001. (Pubitemid 34286101)
13. Fontaine B, Khurana TS, Hoffman EP, Bruns GA, Haines JL, Trofatter JA, Hanson MP, Rich J, McFarlane H, Yasek DM, Romano D, Gusella JF, Brown RH. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250: 1000-1002, 1990. (Pubitemid 120031809)
14. George AL, Crackower MA, Abdalla JA, Hudson AJ, Ebers GC. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nature Genet 3: 305-310, 1993. (Pubitemid 23112954)
15. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100, 1981. (Pubitemid 11012976)
16. Jurkat-Rott K, Lehmann-horn F, Elbaz A, Heine R, Gregg RG, Hogan K, Powers PA, Lapie P, Valesantos JE, Weissenbach J, Fontaine B. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3: 1415-1419, 1994. (Pubitemid 24255482)
17. Koch MC, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Otto M, Zoll B, Lehmann-Horn F, Grzeschik KH, Jentsch TJ. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257: 797-800, 1992.
18. Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, Doyle DA. Crystal structure of the potassium channel KirBac1.1 in the closed state. Science 300: 1922-1926, 2003.
19. + current and of hyperpolarization in human myoblast fusion. J Physiol (Lond) 510: 467-476, 1998.
20. Lopatin AN, Nichols CG. Inward rectifiers in the heart: an update on I(K1). J Mol Cell Cardiol 33: 625-638, 2001.
21. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptáček LJ. Mutations in Kir2 LJ.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511-519, 2001. (Pubitemid 32520856)
22. Ptáček LJ, George AL, Griggs RC, Tawil R, Kallen RG, Barchi RL, Robertson M, Leppert MF. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67: 1021-1027, 1991. (Pubitemid 121001515)
23. Ptáček LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradleyc P, Leppert MF. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77: 863-868, 1994. (Pubitemid 24187684)
24. Ptáček LJ, Trimmer JS, Agnew WS, Roberts JW, Petajan JH, Leppert M. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am J Hum Genet 49: 851-854, 1991. (Pubitemid 21891731)
25. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142: 257-265, 1991.
26. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptáá ček LJ, Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110: 381-388, 2002. (Pubitemid 34847970)
27. Vilquin JT, Marolleau JP, Sacconi S, Garcin I, Lacassagne MN, Robert I, Ternaux B, Bouazza B, Larghero J, Desnuelle C. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther 12: 1651-1662, 2005. (Pubitemid 41670355)
28. + outward current in H9c2 myoblasts. Jap J Physiol 52: 507-514, 2002.
29. Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. Circ Res 87: 160-166, 2000.
30. Zaritsky JJ, Redell JB, Tempel BL, Schwarz TL. The consequences of disrupting cardiac inwardly rectifying K(+) current [I(K1)] as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J Physiol 533: 697-710, 2001.